Medical News Today -
5 Nov 2013 12:00
Biosensors International has announced four- year results from the BioFreedom First in Man study (FIM), which demonstrated similar clinical outcomes between BioFreedomTM, a polymer-free drug-coated stent (DCS), and Boston Scientific's TaxusTM LibertéTM drug-eluting stent (DES), with no evidence of definite and/or probable stent thrombosis. Results were presented by Dr. Ricardo Costa, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil, at the 25th annual Transcatheter Cardiovascular T...
Share this Article